184 patents currently held
23 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.
The next term ends in Jun 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
23
Ending by 2030
Jun 2027
Next term end
117
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2030 · High confidence
Also notable
Ends Jan 2036 · High confidence
Also notable
Ends Nov 2040 · High confidence
System and Method for Detecting, Collecting, Analyzing, and Communicating Event-Related Information
US 10,002,034
The most cited patent in this portfolio, cited by 250 later US patents, top 1% of utility patents granted in 2018 in our data. Protection runs to 2030.
Process and Framework For Facilitating Information Sharing Using a Distributed Hypergraph
US 11,226,945
Cited by 33 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2036.
Method and System for Assessing Drug Efficacy Using Multiple Graph Kernel Fusion
US 11,238,966
Cited by 7 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2040.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 2 to 27, 2026 · next Dec 2
- 6 fees due Jan 4 to 21, 2027 · next Jan 4
- 2 fees due Feb 13 to 15, 2027 · next Feb 13
- 4 fees due Apr 3 to 29, 2027 · next Apr 3
- 4 fees due May 7 to 19, 2027 · next May 7
- 5 fees due Jun 1 to 30, 2027 · next Jun 1
- 5 fees due Jul 2 to 30, 2027 · next Jul 2
- 3 fees due Aug 13 to 25, 2027 · next Aug 13
- 6 fees due Sep 8 to 24, 2027 · next Sep 8
- 4 fees due Oct 5 to 9, 2027 · next Oct 5
- 1 fee due Nov 12, 2027The maintenance fee for Uses of Indolinone Compounds (US 10,646,470) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
- 8 of the patents on this record were granted since Aug 17, 2026
- 4 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 117 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| System and method for detecting, collecting, analyzing, and communicating event-related information | 8 in force | to Feb 2031 |
| Method and System for Assessing Drug Efficacy Using Multiple Graph Kernel Fusion | 5 in force | to Nov 2040 |
| Process and Framework For Facilitating Data Sharing Using a Distributed Hypergraph | 5 in force | to Jul 2038 |
| Immortalization of Epithelial Cells and Methods of Use | 5 in force | to May 2032 |
| Uses of Indolinone Compounds | 4 in force | to Jul 2037 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,888,509 | Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors In force · High confidence | In force | High confidence | |
| US 9,758,481 | Targeting of EWS-FLI1 as Anti-Tumor Therapy In force · High confidence | In force | High confidence | |
| US 9,045,415 | Targeting of EWS-FLI1 as Anti-Tumor Therapy In force · High confidence | In force | High confidence | |
| US 7,725,565 | System and Method for Detecting, Collecting, Analyzing, and Communicating Event Related Information In force · High confidence | In force | High confidence | |
| US 10,055,502 | System and Method for Detecting, Collecting, Analyzing, and Communicating Event Related Information In force · Medium confidence | In force | Medium confidence | |
| US 10,592,310 | System and Method for Detecting, Collecting, Analyzing, and Communicating Event-Related Information In force · Medium confidence | In force | Medium confidence | |
| US 8,232,310 | Targeting of EWS-FLI1 as Anti-Tumor Therapy In force · High confidence | In force | High confidence | |
| US 7,763,734 | Synthesis, Structure and Use of Bisoxazolidines for Asymmetric Catalysis and Synthesis In force · High confidence | In force | High confidence | |
| US 9,489,495 | System and method for detecting, collecting, analyzing, and communicating event-related information In force · High confidence | In force | High confidence | |
| US 10,503,347 | System and Method for Detecting, Collecting, Analyzing, and Communicating Event-Related Information In force · High confidence | In force | High confidence |
Also on record, not counted in the 184: 23 patents in force now held by others · 148 patents ended · 64 applications pending · 169 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.